Login Register Cart 0
Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Pitfalls and Limitations of Platelet Counts and Coagulation Tests in the Neonatal Intensive Care Unit

Author(s): Patricia Davenport* and Martha Sola-Visner*

Volume 19, Issue 4, 2023

Published on: 22 December, 2022

Page: [357 - 365] Pages: 9

DOI: 10.2174/1573396319666221216122444

Price: $65

Abstract

The assessment of hemostasis and the prediction of bleeding risk are of great importance to neonatologists. Premature infants are at an increased risk for bleeding, particularly intra-cranial hemorrhages (most commonly intra-ventricular hemorrhages (IVH)), gastrointestinal hemorrhages, and pulmonary hemorrhages. All severe bleeding, but especially severe IVH, is associated with poor neurodevelopmental outcomes, and other than prenatal steroids, no intervention has reduced the incidence of this serious complication. As a result, there is a need in neonatology to more accurately identify at-risk infants as well as effective interventions to prevent severe bleeding. Unfortunately, the commonly available tests to evaluate the hemostatic system were established using adult physiologic principles and did not consider the neonate's different but developmentally appropriate hemostatic system. This review will describe the changes in the platelet count and tests of hemostasis throughout development, the limitations of these tests to predict neonatal bleeding and the utility of treating abnormal results from these tests with platelet and/or fresh frozen plasma (FFP) transfusions in non-bleeding infants.

« Previous Next »
Graphical Abstract

[1]
Yoffey JM. The stem cell problem in the fetus. Isr J Med Sci 1971; 7(7): 825-33.
[PMID: 4943622]
[2]
Allen G JL, de Alarcon PA. Megakaryocytopoiesis in the human fetus Arch Dis Child 1989; 64(4 Spec No): 481-
[http://dx.doi.org/10.1136/adc.64.4_Spec_No.481]
[3]
De Alarcon PA, Graeve JLA. Analysis of megakaryocyte ploidy in fetal bone marrow biopsies using a new adaptation of the feulgen tech-nique to measure DNA content and estimate megakaryocyte ploidy from biopsy specimens. Pediatr Res 1996; 39(1): 166-70.
[http://dx.doi.org/10.1203/00006450-199601000-00026] [PMID: 8825404]
[4]
Izumi T, Kawakami M, Enzan H, Ohkita T. The size of megakaryocytes in human fetal, infantile and adult hematopoiesis. Hiroshima J Med Sci 1983; 32(3): 257-60.
[PMID: 6643104]
[5]
Izumi T. Morphometric studies of megakaryocytes in human and rat fetal, infantile and adult hematopoiesis. II. Observations on rat fetus-es and adult rats. Hiroshima J Med Sci 1987; 36(1): 31-7.
[PMID: 3583803]
[6]
Lefrançais E, Ortiz-Muñoz G, Caudrillier A, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature 2017; 544(7648): 105-9.
[http://dx.doi.org/10.1038/nature21706] [PMID: 28329764]
[7]
Aballi AJ, Puapondh Y, Desposito F. Platelet counts in thriving premature infants. Pediatrics 1968; 42(4): 685-9.
[http://dx.doi.org/10.1542/peds.42.4.685] [PMID: 5681287]
[8]
Ablin AR, Kushner JH, Murphy A, Zippin C. Platelet enumeration in the neonatal period. Pediatrics 1961; 28(5): 822-4.
[http://dx.doi.org/10.1542/peds.28.5.822] [PMID: 13858959]
[9]
Sell EJ, Corrigan JJ Jr. Platelet counts, fibrinogen concentrations, and factor V and factor VIII levels in healthy infants according to gesta-tional age. J Pediatr 1973; 82(6): 1028-32.
[http://dx.doi.org/10.1016/S0022-3476(73)80436-6] [PMID: 4702894]
[10]
Wiedmeier SE, Henry E, Sola-Visner MC, Christensen RD. Platelet reference ranges for neonates, defined using data from over 47 000 patients in a multihospital healthcare system. J Perinatol 2009; 29(2): 130-6.
[http://dx.doi.org/10.1038/jp.2008.141] [PMID: 18818663]
[11]
Ferrer-Marin F, Sola-Visner M. Neonatal platelet physiology and implications for transfusion. Platelets 2021; 2021: 1-9.
[PMID: 34392772]
[12]
Israels SJ, Cheang T, Roberston C, McMillan-Ward EM, McNicol A. Impaired signal transduction in neonatal platelets. Pediatr Res 1999; 45(5 Pt 1): 687-91.
[http://dx.doi.org/10.1203/00006450-199905010-00014] [PMID: 10231866]
[13]
Sitaru AG, Holzhauer S, Speer CP, et al. Neonatal platelets from cord blood and peripheral blood. Platelets 2005; 16(3-4): 203-10.
[http://dx.doi.org/10.1080/09537100400016862] [PMID: 16011965]
[14]
Hardy A, Palma-Barqueros V, Watson S, et al. Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia. Thromb Haemost 2018; 118(6): 1009-20.
[http://dx.doi.org/10.1055/s-0038-1646924] [PMID: 29695020]
[15]
Bednarek FJ, Bean S, Barnard MR, Frelinger AL, Michelson AD. The platelet hyporeactivity of extremely low birth weight neonates is age-dependent. Thromb Res 2009; 124(1): 42-5.
[http://dx.doi.org/10.1016/j.thromres.2008.10.004] [PMID: 19026437]
[16]
Andrew M, Paes B, Bowker J, Vegh P. Evaluation of an automated bleeding time device in the newborn. Am J Hematol 1990; 35(4): 275-7.
[http://dx.doi.org/10.1002/ajh.2830350411] [PMID: 2239923]
[17]
Carcao MD, Blanchette VS, Dean JA, et al. The Platelet Function Analyzer (PFA-100®): a novel in-vitro system for evaluation of primary haemostasis in children. Br J Haematol 1998; 101(1): 70-3.
[http://dx.doi.org/10.1046/j.1365-2141.1998.00656.x] [PMID: 9576184]
[18]
Israels SJ, Cheang T, McMillan-Ward EM, Cheang M. Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. J Pediatr 2001; 138(1): 116-9.
[http://dx.doi.org/10.1067/mpd.2001.109794] [PMID: 11148524]
[19]
Roschitz B, Sudi K, Köstenberger M, Muntean W. Shorter PFA-100® closure times in neonates than in adults: role of red cells, white cells, platelets and von Willebrand factor. Acta Paediatr 2001; 90(6): 664-70.
[http://dx.doi.org/10.1111/j.1651-2227.2001.tb02431.x] [PMID: 11440101]
[20]
Boudewijns M, Raes M, Peeters V, et al. Evaluation of platelet function on cord blood in 80 healthy term neonates using the Platelet Func-tion Analyser (PFA-100): shorter in vitro bleeding times in neonates than adults. Eur J Pediatr 2003; 162(3): 212-3.
[http://dx.doi.org/10.1007/s00431-002-1093-7] [PMID: 12659096]
[21]
Gerrard JM, Docherty JC, Israels SJ, et al. A reassessment of the bleeding time: association of age, hematocrit, platelet function, von Wil-lebrand factor, and bleeding time thromboxane B2 with the length of the bleeding time. Clin Invest Med 1989; 12(3): 165-71.
[PMID: 2787219]
[22]
Saxonhouse MA, Garner R, Mammel L, et al. Closure times measured by the platelet function analyzer PFA-100 are longer in neonatal blood compared to cord blood samples. Neonatology 2010; 97(3): 242-9.
[http://dx.doi.org/10.1159/000253755] [PMID: 19887853]
[23]
Dreyfus M, Kaplan C, Verdy E, Schlegel N, Durand-Zaleski I, Tchernia G. Frequency of immune thrombocytopenia in newborns: a pro-spective study. Blood 1997; 89(12): 4402-6.
[http://dx.doi.org/10.1182/blood.V89.12.4402] [PMID: 9192764]
[24]
Uhrynowska M, Maslanka K, Zupanska B. Neonatal thrombocytopenia: incidence, serological and clinical observations. Am J Perinatol 1997; 14(7): 415-8.
[http://dx.doi.org/10.1055/s-2007-994171] [PMID: 9263562]
[25]
Castle V, Andrew M, Kelton J, Giron D, Johnston M, Carter C. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 1986; 108(5): 749-55.
[http://dx.doi.org/10.1016/S0022-3476(86)81059-9] [PMID: 3701523]
[26]
Mehta P, Vasa R, Neumann L, Karpatkin M. Thrombocytopenia in the high-risk infant. J Pediatr 1980; 97(5): 791-4.
[http://dx.doi.org/10.1016/S0022-3476(80)80272-1] [PMID: 7431175]
[27]
Ören H, Irken G, Ören B, Olgun N, Özkan H. Assessment of clinical impact and predisposing factors for neonatal thrombocytopenia. Indian J Pediatr 1994; 61(5): 551-8.
[http://dx.doi.org/10.1007/BF02751717] [PMID: 7744455]
[28]
Christensen RD, Henry E, Wiedmeier SE, et al. Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system. J Perinatol 2006; 26(6): 348-53.
[http://dx.doi.org/10.1038/sj.jp.7211509] [PMID: 16642027]
[29]
MacQueen BC, Christensen RD, Henry E, et al. The immature platelet fraction: creating neonatal reference intervals and using these to categorize neonatal thrombocytopenias. J Perinatol 2017; 37(7): 834-8.
[http://dx.doi.org/10.1038/jp.2017.48] [PMID: 28383532]
[30]
Baer VL, Lambert DK, Henry E, Christensen RD. Severe Thrombocytopenia in the NICU. Pediatrics 2009; 124(6): e1095-100.
[http://dx.doi.org/10.1542/peds.2009-0582] [PMID: 19917581]
[31]
Muthukumar P, Venkatesh V, Curley A, et al. Severe thrombocytopenia and patterns of bleeding in neonates: results from a prospective observational study and implications for use of platelet transfusions. Transfus Med 2012; 22(5): 338-43.
[http://dx.doi.org/10.1111/j.1365-3148.2012.01171.x] [PMID: 22738179]
[32]
Stanworth SJ, Clarke P, Watts T, et al. Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics 2009; 124(5): e826-34.
[http://dx.doi.org/10.1542/peds.2009-0332] [PMID: 19841111]
[33]
Deschmann E, Saxonhouse MA, Feldman HA, Norman M, Barbian M. Sola-visner m. association of bleeding scores and platelet transfu-sions with platelet counts and closure times in response to adenosine diphosphate (CT-ADPs) among preterm neonates with thrombocy-topenia. JAMA Netw Open 2020; 3(4), e203394.
[http://dx.doi.org/10.1001/jamanetworkopen.2020.3394] [PMID: 32338750]
[34]
Deschmann E, Saxonhouse MA, Feldman HA, Norman M, Barbian M, Sola-Visner M. Association between in vitro bleeding time and bleeding in preterm infants with thrombocytopenia. JAMA Pediatr 2019; 173(4): 393-4.
[http://dx.doi.org/10.1001/jamapediatrics.2019.0008] [PMID: 30801615]
[35]
Sparger KA, Assmann SF, Granger S, et al. Platelet transfusion practices among very-low-birth-weight infants. JAMA Pediatr 2016; 170(7): 687-94.
[http://dx.doi.org/10.1001/jamapediatrics.2016.0507] [PMID: 27213618]
[36]
von Lindern JS, van den Bruele T, Lopriore E, Walther FJ. Thrombocytopenia in neonates and the risk of intraventricular hemorrhage: A retrospective cohort study. BMC Pediatr 2011; 11(1): 16.
[http://dx.doi.org/10.1186/1471-2431-11-16] [PMID: 21314921]
[37]
Josephson CD, Granger S, Assmann SF, et al. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia. Blood 2012; 120(4): 748-60.
[http://dx.doi.org/10.1182/blood-2011-11-389569] [PMID: 22538854]
[38]
Fustolo-Gunnink SF, Fijnvandraat K, Putter H, et al. Dynamic prediction of bleeding risk in thrombocytopenic preterm neonates. Haematologica 2019; 104(11): 2300-6.
[http://dx.doi.org/10.3324/haematol.2018.208595] [PMID: 30819913]
[39]
Cremer M, Sola-Visner M, Roll S, et al. Platelet transfusions in neonates: Practices in the United States vary significantly from those in Austria, Germany, and Switzerland. Transfusion 2011; 51(12): 2634-41.
[http://dx.doi.org/10.1111/j.1537-2995.2011.03208.x] [PMID: 21658049]
[40]
Josephson CD, Su LL, Christensen RD, et al. Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics 2009; 123(1): 278-85.
[http://dx.doi.org/10.1542/peds.2007-2850] [PMID: 19117893]
[41]
Patel RM, Hendrickson JE, Nellis ME, et al. Variation in neonatal transfusion practice. J Pediatr 2021; 235: 92-99.e4.
[http://dx.doi.org/10.1016/j.jpeds.2021.04.002] [PMID: 33836184]
[42]
Andrew M, Vegh P, Caco C, et al. A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993; 123(2): 285-91.
[http://dx.doi.org/10.1016/S0022-3476(05)81705-6] [PMID: 8345429]
[43]
Curley A, Stanworth SJ, Willoughby K, et al. Randomized trial of platelet-transfusion thresholds in neonates. N Engl J Med 2019; 380(3): 242-51.
[http://dx.doi.org/10.1056/NEJMoa1807320] [PMID: 30387697]
[44]
Fustolo-Gunnink SF, Fijnvandraat K, van Klaveren D, et al. Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death. Blood 2019; 134(26): 2354-60.
[http://dx.doi.org/10.1182/blood.2019000899] [PMID: 31697817]
[45]
von Lindern JS, Hulzebos CV, Bos AF, Brand A, Walther FJ, Lopriore E. Thrombocytopaenia and intraventricular haemorrhage in very premature infants: a tale of two cities. Arch Dis Child Fetal Neonatal Ed 2012; 97(5): F348-52.
[http://dx.doi.org/10.1136/fetalneonatal-2011-300763] [PMID: 22933094]
[46]
Del Vecchio A, Sola MC, Theriaque DW, et al. Platelet transfusions in the neonatal intensive care unit:factors predicting which patients will require multiple transfusions. Transfusion 2001; 41(6): 803-8.
[http://dx.doi.org/10.1046/j.1537-2995.2001.41060803.x] [PMID: 11399824]
[47]
Garcia MG, Duenas E, Sola MC, Hutson AD, Theriaque D, Christensen RD. Epidemiologic and outcome studies of patients who received platelet transfusions in the neonatal intensive care unit. J Perinatol 2001; 21(7): 415-20.
[http://dx.doi.org/10.1038/sj.jp.7210566] [PMID: 11894507]
[48]
Baer VL, Lambert DK, Henry E, Snow GL, Sola-Visner MC, Christensen RD. Do platelet transfusions in the NICU adversely affect sur-vival? Analysis of 1600 thrombocytopenic neonates in a multihospital healthcare system. J Perinatol 2007; 27(12): 790-6.
[http://dx.doi.org/10.1038/sj.jp.7211833] [PMID: 17855804]
[49]
Patel RM, Josephson CD, Shenvi N, et al. Platelet transfusions and mortality in necrotizing enterocolitis. Transfusion 2019; 59(3): 981-8.
[http://dx.doi.org/10.1111/trf.15112] [PMID: 30597571]
[50]
Kenton AB, Hegemier S, Smith EOB, et al. Platelet transfusions in infants with necrotizing enterocolitis do not lower mortality but may increase morbidity. J Perinatol 2005; 25(3): 173-7.
[http://dx.doi.org/10.1038/sj.jp.7211237] [PMID: 15578029]
[51]
Pal S, Curley A, Stanworth SJ. Interpretation of clotting tests in the neonate: Table 1. Arch Dis Child Fetal Neonatal Ed 2015; 100(3): F270-4.
[http://dx.doi.org/10.1136/archdischild-2014-306196] [PMID: 25414486]
[52]
Achey MA, Nag UP, Robinson VL, et al. The developing balance of thrombosis and hemorrhage in pediatric surgery: clinical implications of age-related changes in hemostasis. Clin Appl Thromb Hemost 2020; 26, 1076029620929092.
[http://dx.doi.org/10.1177/1076029620929092] [PMID: 32584601]
[53]
Pichler E, Pichler L. The neonatal coagulation system and the vitamin K deficiency bleeding-a mini review. Wien Med Wochenschr 2008; 158(13-14): 385-95.
[http://dx.doi.org/10.1007/s10354-008-0538-7] [PMID: 18677590]
[54]
Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70(1): 165-72.
[http://dx.doi.org/10.1182/blood.V70.1.165.165] [PMID: 3593964]
[55]
Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72(5): 1651-7.
[http://dx.doi.org/10.1182/blood.V72.5.1651.1651] [PMID: 3179444]
[56]
Christensen RD, Baer VL, Lambert DK, Henry E, Ilstrup SJ, Bennett ST. Reference intervals for common coagulation tests of preterm infants (CME). Transfusion 2014; 54(3): 627-32.
[http://dx.doi.org/10.1111/trf.12322] [PMID: 23834237]
[57]
Neary E, Okafor I, Al-Awaysheh F, et al. Laboratory coagulation parameters in extremely premature infants born earlier than 27 gesta-tional weeks upon admission to a neonatal intensive care unit. Neonatology 2013; 104(3): 222-7.
[http://dx.doi.org/10.1159/000353366] [PMID: 24030102]
[58]
Neary E, McCallion N, Kevane B, et al. Coagulation indices in very preterm infants from cord blood and postnatal samples. J Thromb Haemost 2015; 13(11): 2021-30.
[http://dx.doi.org/10.1111/jth.13130] [PMID: 26334448]
[59]
Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992; 80(8): 1998-2005.
[http://dx.doi.org/10.1182/blood.V80.8.1998.1998] [PMID: 1391957]
[60]
Barnes C, Ignjatovic V, Furmedge J, et al. Developmental haemostasis. Thromb Haemost 2006; 95(2): 362-72.
[http://dx.doi.org/10.1160/TH05-01-0047] [PMID: 16493500]
[61]
Cvirn G, Gallistl S, Rehak T, Jürgens G, Muntean W. Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma. J Thromb Haemost 2003; 1(8): 1785-90.
[http://dx.doi.org/10.1046/j.1538-7836.2003.00320.x] [PMID: 12911594]
[62]
Andrew M. The hemostatic system in the infantHematology of Infancy and Childhood. Philadelphia: WB Saunders 1992; p. 119.
[63]
Goel R, Josephson CD, Patel EU, et al. Individual‐ and hospital‐level correlates of red blood cell, platelet, and plasma transfusions among hospitalized children and neonates: a nationally representative study in the United States. Transfusion 2020; 60(8): 1700-12.
[http://dx.doi.org/10.1111/trf.15855] [PMID: 32589286]
[64]
Amrutiya RJ, Mungala BM, Patel VT, Ganjiwale JD, Nimbalkar SM. Blood component transfusion in tertiary care neonatal intensive care unit and neonatal intermediate care unit: an audit. Cureus 2020; 12(8), e9952.
[http://dx.doi.org/10.7759/cureus.9952] [PMID: 32983658]
[65]
Altuntas N, Yenicesu İ, Beken S, et al. Clinical use of fresh-frozen plasma in neonatal intensive care unit. Transfus Apheresis Sci 2012; 47(1): 91-4.
[http://dx.doi.org/10.1016/j.transci.2012.05.007] [PMID: 22640835]
[66]
Raban MS, Harrison MC. Fresh frozen plasma use in a neonatal unit in South Africa. J Trop Pediatr 2015; 61(4): 266-71.
[http://dx.doi.org/10.1093/tropej/fmv027] [PMID: 25920397]
[67]
Catford K, Muthukumar P, Reddy C, et al. Routine neonatal coagulation testing increases use of fresh-frozen plasma. Transfusion 2014; 54(5): 1444-5.
[http://dx.doi.org/10.1111/trf.12610] [PMID: 24819080]
[68]
Dogra K, Kaur G, Basu S, Chawla D. Fresh frozen plasma and platelet transfusion practices in neonatal intensive care unit of a tertiary care hospital. Indian J Hematol Blood Transfus 2020; 36(1): 141-8.
[http://dx.doi.org/10.1007/s12288-019-01164-z] [PMID: 32158097]
[69]
Baer VL, Lambert DK, Schmutz N, et al. Adherence to NICU transfusion guidelines: Data from a multihospital healthcare system. J Perinatol 2008; 28(7): 492-7.
[http://dx.doi.org/10.1038/jp.2008.23] [PMID: 18337739]
[70]
Motta M, Del Vecchio A, Perrone B, Ghirardello S, Radicioni M. Fresh frozen plasma use in the NICU: A prospective, observational, mul-ticentred study. Arch Dis Child Fetal Neonatal Ed 2014; 99(4): F303-8.
[http://dx.doi.org/10.1136/archdischild-2013-304747] [PMID: 24646616]
[71]
Puetz J, Darling G, McCormick KA, Wofford JD. Fresh frozen plasma and recombinant factor VIIa use in neonates. J Pediatr Hematol Oncol 2009; 31(12): 901-6.
[http://dx.doi.org/10.1097/MPH.0b013e3181c29c25] [PMID: 19956022]
[72]
Nellis ME, Goel R, Hendrickson JE, et al. Transfusion practices in a large cohort of hospitalized children. Transfusion 2021; 61(7): 2042-53.
[http://dx.doi.org/10.1111/trf.16443] [PMID: 33973660]
[73]
Houben NAM, Heeger LE, Stanworth SJ, et al. Changes in the use of fresh-frozen plasma transfusions in preterm neonates: A single cen-ter experience. J Clin Med 2020; 9(11): 3789.
[http://dx.doi.org/10.3390/jcm9113789] [PMID: 33238649]
[74]
Székely A, Cserép Z, Sápi E, et al. Risks and predictors of blood transfusion in pediatric patients undergoing open heart operations. Ann Thorac Surg 2009; 87(1): 187-97.
[http://dx.doi.org/10.1016/j.athoracsur.2008.09.079] [PMID: 19101294]
[75]
Qin CX, Yesantharao LV, Merkel KR, et al. Blood utilization and clinical outcomes in extracorporeal membrane oxygenation patients. Anesth Analg 2020; 131(3): 901-8.
[http://dx.doi.org/10.1213/ANE.0000000000004807] [PMID: 32304461]
[76]
Forman KR, Diab Y, Wong ECC, Baumgart S, Luban NLC, Massaro AN. Coagulopathy in newborns with hypoxic ischemic encephalopa-thy (HIE) treated with therapeutic hypothermia: a retrospective case-control study. BMC Pediatr 2014; 14(1): 277.
[http://dx.doi.org/10.1186/1471-2431-14-277] [PMID: 25367591]
[77]
Tran TTH, Veldman A, Malhotra A. Does risk-based coagulation screening predict intraventricular haemorrhage in extreme premature infants? Blood Coagul Fibrinolysis 2012; 23(6): 532-6.
[http://dx.doi.org/10.1097/MBC.0b013e3283551145] [PMID: 22627584]
[78]
Elbourne D. A randomized trial comparing the effect of prophylactic intravenous fresh frozen plasma, gelatin or glucose on early mortality and morbidity in preterm babies. Eur J Pediatr 1996; 155(7): 580-8.
[http://dx.doi.org/10.1007/BF01957909] [PMID: 8831082]
[79]
Northern Neonatal Nursing Initiative Trial Group.Randomised trial of prophylactic early fresh-frozen plasma or gelatin or glucose in pre-term babies: outcome at 2 years. Lancet 1996; 348(9022): 229-32.
[http://dx.doi.org/10.1016/S0140-6736(95)12506-X] [PMID: 8684200]
[80]
Hambleton G, Appleyard WJ. Controlled trial of fresh frozen plasma in asphyxiated low birthweight infants. Arch Dis Child 1973; 48(1): 31-5.
[http://dx.doi.org/10.1136/adc.48.1.31] [PMID: 4685591]
[81]
Gross SJ, Filston HC, Anderson JC. Controlled study of treatment for disseminated intravascular coagulation in the neonate. J Pediatr 1982; 100(3): 445-8.
[http://dx.doi.org/10.1016/S0022-3476(82)80457-5] [PMID: 7038076]
[82]
Davenport P, Sola-Visner M. Hemostatic challenges in neonates. Front Pediatr 2021; 9, 627715.
[http://dx.doi.org/10.3389/fped.2021.627715] [PMID: 33738269]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy